This is our Regulatory Landscape newsletter for November 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of October, there were 75 new Regulatory jobs posted across the country at small and midsized bio/pharma companies. This is down 31% from last October, and very similar to the job numbers[…]
Pay transparency is coming to the biopharma industry. In fact, there’s already some form of law in place in California, Colorado, Connecticut, Maryland, and Washington with new transparency laws enacting in New York on November 1, 2022. Job boards such as Indeed are seeing an increase in companies sharing salary ranges. LinkedIn’s latest Workforce Confidence[…]
This is our Regulatory Landscape newsletter for August 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of July, there were only 70 new Regulatory jobs posted across the country at small and midsized bio/pharma companies. This is down 30% from prior months, but we always see a big[…]
In April of this year we surveyed Regulatory professionals about their motivations to make a job change. At that time, 79% of Regulatory professionals considering a job change were motivated to do so by gaining the ability to work remotely. From my discussions with hundreds of candidates, I have learned that very few people want[…]
This is our Regulatory Landscape newsletter for July 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of June, there were over 100 new Regulatory roles posted as smaller and mid-sized biotech and pharma companies. This is down a bit from May but in line with what we saw[…]
In today’s market, it’s incredibly challenging to find the desired Regulatory talent for growing bio/pharma organizations. We’ve seen companies adjust levels, rapidly promote people, and lower their expectations. It’s an arduous process but once you finally are ready to make an offer, it’s becoming increasingly difficult to get the acceptance. The biggest challenge is that[…]
This is our Regulatory Landscape newsletter for June 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of May, there were over 125 new Regulatory roles posted as smaller and mid-sized biotech and pharma companies. This is a noticeable increase in new postings compared to the past few months. […]
This is our Regulatory Landscape newsletter for May 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of April, there were 94 new Regulatory job postings at small and mid sized biopharma companies. This is down slightly from March, but we usually see a small decline in April each[…]
Dennis Partners conducted a survey in June 2021 to determine if and how The Great Resignation was impacting Regulatory Affairs professionals and their motivations to stay in their current position or seek a new one (survey results here). In order to better understand how Regulatory professionals are feeling about the current job market in 2022,[…]
This is our Regulatory Landscape newsletter for April 2022 with our monthly insights on the evolving market for regulatory professionals. For the month of March we saw over 110 new Regulatory job postings at mid-sized and smaller biopharma companies. The majority of these are at Director level or higher, including 11 new Vice President-level Regulatory[…]
